COVID-19 Therapeutics Whirlwind webinar

6.00 pm AEST Welcome and introduction
Professor Jason Roberts, The University of Queensland CRE REDUCE

6.05 pm | 7.05 pm AEDT Lessons learned for running clinical trials in a pandemic
A/Prof Steven Tong, The Doherty Institute, Australia

6.25 pm AEST  Latest data for steroids in COVID-19
Prof Bala Venkatesh, The George Institute for Global Health | Wesley Medical Research, Australia

6.45 pm | 2.45 am CST  Antiviral drugs for SARS-CoV-2
Prof Andre Kalil, University of Nebraska Medical Center, United States of America

7.05pm | 8.05pm AEDT  Antibody therapy for COVID-19
A/Prof Zoe McQuilten, Monash University, Australia

7.25 pm  IL-6 pathway inhibitors for COVID-19
A/Prof Bridget Barber, QIMR Berghofer Medical Research Institute, Australia

7.45 pm | 3.15 pm IST  What approaches for thromboprophylaxis should be therapy for COVID-19?
Dr M Joseph John, Christian Medical College Ludhiana, Punjab

8.05 pm | 11.05 am CET  How does critical illness change treatment approaches to COVID-19?
Prof Jan De Waele, Ghent University Hospital, Belgium

8.25 pm |  11.25 am CET  A national healthcare response to intensive care bed requirements during the COVID-19 outbreak in France
Prof Jean-Yves Lefrant, Centre Hospitalier Universitaire de Nîmes, France

8.45pm AEST | 9.45pm AEDT | 11.45am CET | 4.45am CST | 4.15 PM IST   Close